How long does a Mounjaro approval last with Wisconsin Medicaid?

Initial approvals last 6 months, and renewals are granted in 12-month periods.

What does Wisconsin Medicaid require to renew Mounjaro?

Improvement in A1C and Member must have been adherent with prescribed treatment regimen AND have a reduction in HbA1c compared to baseline prior to initiation of the non-preferred GLP-1 agent.

How current is this information?

This page reflects Wisconsin Medicaid's written policy as of its current version, last verified against the source document on June 3, 2026.

Does Wisconsin Medicaid cover Mounjaro?

Mounjaro for Type 2 Diabetes

What Wisconsin Medicaid requires, by plan type. Open this indication on its own page →

Medicaid

Covered with requirements

What you need to qualify

A1C of 6.5% or higher
Diagnosis documented with a code
Prior trial of 2 other GLP-1 medications (preferred GLP-1 agents (at least 2)) for at least 90 days
Lab results confirming eligibility

Qualification pathways

You can qualify through any one of these.

Non-preferred GLP-1 approval for T2DM

All of:

Drug is prescribed consistent with FDA-approved labeling
Member has type 2 diabetes mellitus
HbA1c measured within the past 6 months
If not currently on a GLP-1 agent: most recent HbA1c >= 6.5%
For at least 2 preferred GLP-1 agents: documented trial at maximum dose for >= 3 consecutive months with unsatisfactory glycemic response, OR clinically significant adverse drug reaction

Documentation to bring

Completed and signed Prior Authorization Drug Attachment for Hypoglycemics, GLP-1 Agents (Form F-00238)
Completed PA/RF (Prior Authorization Request Form, F-11018)
Copy of member's current medical records documenting the medical condition being treated
Details regarding previous GLP-1 medication use (at least 2 preferred GLP-1 agents trialed)
Member's current treatment plan
Member's current HbA1c lab report (within past 6 months)
For step therapy failure pathway: HbA1c measured after member has been taking the maximum dose of a preferred agent for at least 3 consecutive months
For adverse reaction pathway: documentation of clinically significant adverse drug reaction with preferred GLP-1 agent(s)

Approval and renewal

Initial approval: 6 months
Renewal: every 12 months
To renew, the plan looks for improvement in A1C and Member must have been adherent with prescribed treatment regimen AND have a reduction in HbA1c compared to baseline prior to initiation of the non-preferred GLP-1 agent.

Not covered when

Nonadherence to previous GLP-1 treatment is not valid criteria
Member's fear of needles is not valid criteria
Member's or prescriber's preference for an oral agent is not valid criteria
Member's or prescriber's preference for the non-preferred GLP-1 agent is not valid criteria
Member's or prescriber's preference for less frequent dosing schedule is not valid criteria
Type 1 diabetes

Policy note: This is a Wisconsin ForwardHealth (Medicaid) policy. The document covers non-preferred GLP-1 agents as a class; preferred GLP-1 agents require only a valid diagnosis code on claims without a separate PA. The A1C >= 6.5% threshold applies only if the member is NOT currently on a GLP-1 agent. Initial PA approved for up to 183 days (~6 months); renewal approved up to 365 days. Step therapy requires trial and failure or adverse reaction with at least 2 preferred GLP-1 agents. The document does not name specific preferred vs. non-preferred agents; Mounjaro is classified as non-preferred based on document context. Mounjaro has a T2DM indication only in this in-scope list; weight_loss is not addressed by this document.

verified June 3, 2026 · source: Pa policy

Why Mounjaro requests get denied by Wisconsin Medicaid

Based on what this policy asks for. Fix these before the first submission.

Wrong brand for the diagnosis. Mounjaro and Zepbound are the same molecule with different approved uses; a request for Mounjaro under a diagnosis that matches Zepbound is routinely denied.
Diagnosis code missing or wrong on the request.
No recent A1C result on file.
Required prior medication trials not documented.

Frequently asked questions

Does Wisconsin Medicaid cover Mounjaro?: Wisconsin Medicaid covers Mounjaro for type 2 diabetes with prior authorization on Medicaid.
How long does a Mounjaro approval last with Wisconsin Medicaid?: Initial approvals last 6 months, and renewals are granted in 12-month periods.
What does Wisconsin Medicaid require to renew Mounjaro?: Improvement in A1C and Member must have been adherent with prescribed treatment regimen AND have a reduction in HbA1c compared to baseline prior to initiation of the non-preferred GLP-1 agent.
How current is this information?: This page reflects Wisconsin Medicaid's written policy as of its current version, last verified against the source document on June 3, 2026.